NYSE:ACH Accendra Health (ACH) Stock Price, News & Analysis $2.56 -0.27 (-9.54%) As of 03:58 PM Eastern Add Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Accendra Health Stock (NYSE:ACH) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Accendra Health alerts:Sign Up Key Stats Today's Range$2.55▼$2.8050-Day Range N/A52-Week Range$1.84▼$9.55Volume729,647 shsAverage Volume930,345 shsMarket Capitalization$196.04 millionP/E RatioN/ADividend YieldN/APrice Target$5.17Consensus RatingHold Company Overview Accendra Health Inc is a nationwide provider of products, technology, and services that support health beyond the hospital by connecting patients, providers, and insurers. Through its brands, Apria and Byram Healthcare, the company delivers disposable medical supplies, integrated home healthcare equipment, and related services that help improve health outcomes and quality of life for individuals with chronic, complex, and acute health conditions. Its offerings span diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment, along with patient support services. The company also supplies a broad range of home medical equipment and patient care products, including ostomy, wound care, urology, and incontinence solutions. Read More Accendra Health Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks64th Percentile Overall ScoreACH MarketRank™: Accendra Health scored higher than 64% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion4.1 / 5Analyst RatingHold Consensus RatingAccendra Health has received a consensus rating of Hold. The company's average rating score is 2.20, and is based on no strong buy ratings, 2 buy ratings, 2 hold ratings, and 1 sell rating.Upside PotentialAccendra Health has a consensus price target of $5.17, representing about 101.8% upside from its current price of $2.56.Amount of Analyst CoverageAccendra Health has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Accendra Health's stock forecast and price target. Earnings and Valuation2.9 / 5Proj. Earnings Growth54.84% Earnings GrowthEarnings for Accendra Health are expected to grow by 54.84% in the coming year, from $0.31 to $0.48 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Accendra Health is 4.16, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 38.81.Price to Earnings Growth RatioAccendra Health has a PEG Ratio of 4.36. PEG Ratios above 1 indicate that a company could be overvalued. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted7.81% of the float of Accendra Health has been sold short.Short Interest Ratio / Days to CoverAccendra Health has a short interest ratio ("days to cover") of 5.16.Change versus previous monthShort interest in Accendra Health has recently decreased by 1.73%, indicating that investor sentiment is improving. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldAccendra Health does not currently pay a dividend.Dividend GrowthAccendra Health does not have a long track record of dividend growth. News and Social Media0.0 / 5News SentimentN/A Search InterestOnly 3 people have searched for ACH on MarketBeat in the last 30 days. This is a decrease of -67% compared to the previous 30 days. Company Ownership0.1 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Accendra Health insiders have not sold or bought any company stock.Percentage Held by Insiders2.29% of the stock of Accendra Health is held by insiders.Percentage Held by InstitutionsAccendra Health has minimal institutional ownership at this time.Read more about Accendra Health's insider trading history. Receive ACH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Accendra Health and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ACH Stock News HeadlinesAccendra Health Announces Offers and Consent SolicitationsMay 22, 2026 | businesswire.comAccendra Health Shareholders Approve Amended Omnibus Incentive PlanMay 15, 2026 | tipranks.com$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s known for playing his cards “close to the vest”… Is going to give you the name and ticker symbol of a company he believes will skyrocket thanks to the coming Starlink IPO…June 3 at 1:00 AM | Paradigm Press (Ad)Accendra Health, Inc. (ACH) Shareholder/Analyst Call Prepared Remarks TranscriptMay 14, 2026 | seekingalpha.comAccendra Health, Inc. (NYSE:ACH) Q1 2026 Earnings Call TranscriptMay 12, 2026 | insidermonkey.comAccendra Health Makes Progress Addressing Its Debt LoadMay 11, 2026 | seekingalpha.comAccendra Health, Inc. (ACH) Q1 2026 Earnings Call TranscriptMay 11, 2026 | seekingalpha.comAccendra Health Reports First Quarter 2026 Financial Results and Announces Comprehensive Balance Sheet Optimization TransactionMay 11, 2026 | businesswire.comSee More Headlines ACH Stock Analysis - Frequently Asked Questions How have ACH shares performed this year? Accendra Health's stock was trading at $2.64 on January 1st, 2026. Since then, ACH shares have decreased by 3.0% and is now trading at $2.56. How were Accendra Health's earnings last quarter? Accendra Health, Inc. (NYSE:ACH) announced its quarterly earnings results on Monday, May, 11th. The company reported ($0.04) EPS for the quarter, topping analysts' consensus estimates of ($0.06) by $0.02. The firm earned $627.78 million during the quarter. Accendra Health had a negative trailing twelve-month return on equity of 13.18% and a negative net margin of 39.84%. Who are Accendra Health's major shareholders? Top institutional investors of Accendra Health include Bank of America Corp DE (4.45%), Dimensional Fund Advisors LP (3.41%), Paradigm Capital Management Inc. NY (2.33%) and Renaissance Technologies LLC (0.42%). How do I buy shares of Accendra Health? Shares of ACH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings5/11/2026Today6/03/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (1d) 1-Year History Jun 25 Sep 25 Dec 25 Mar 26 Jun 26 ACH's financial health is in the Green zone, according to TradeSmith. Industry, Sector and Symbol Stock ExchangeNYSE SectorN/A Industry WHOLESALE - MEDICAL, DENTAL & HOSPITAL EQUIPMENT & SUPPLIES Sub-IndustryN/A Current SymbolNYSE:ACH CIK75252 Webwww.accendrahealth.com Phone(804) 277-4304Fax804-723-7100Employees6,500Year FoundedN/APrice Target and Rating Average Price Target for Accendra Health$5.17 High Price Target$6.00 Low Price Target$4.50 Potential Upside/Downside+101.8%Consensus RatingHold Rating Score (0-4)2.20 Research Coverage5 Analysts Profitability EPS (Trailing Twelve Months)($14.05) Trailing P/E Ratio4.16 Forward P/E Ratio8.26 P/E Growth4.36Net Income-$1.10 billion Net Margins-39.84% Pretax Margin-4.15% Return on Equity-13.18% Return on Assets1.65% Debt Debt-to-Equity RatioN/A Current Ratio0.49 Quick Ratio0.43 Sales & Book Value Annual Sales$2.73 billion Price / Sales0.07 Cash Flow$3.46 per share Price / Cash Flow0.74 Book Value($5.96) per share Price / Book-0.43Miscellaneous Outstanding Shares76,580,000Free Float74,830,000Market Cap$196.04 million OptionableN/A Beta1.62 The 7 Hottest IPOs On Wall Street’s 2026 WatchlistMarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.Get This Free Report This page (NYSE:ACH) was last updated on 6/3/2026 by MarketBeat.com Staff. From Our PartnersYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredJune 12: $100 Turns Into $100,000?The SpaceX IPO is scheduled for June 12, and former tech executive Jeff Brown - who identified Bitcoin, Tesla,...Brownstone Research | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredSpaceX just filed. The clock is ticking.Reuters reports Elon Musk filed secretly. Barron's says it's being finalized behind closed doors. CNBC just re...The Oxford Club | SponsoredSpaceX will mint billionaires. You won't be one of them.By the time a company goes public, 95% of profits have already been made. Insiders bought SpaceX at $20 billio...Behind the Markets | SponsoredSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | SponsoredHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | SponsoredElon’s AI supercomputer just went live. Here’s my #1 stock.Is Elon about to trigger another 315X opportunity? Elon gave Tesla investors the chance to make more than 3...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Accendra Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Accendra Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
